Jeremy Adler, MD, MSc

Jeremy Adler, MD, Mac
Clinical Professor of Pediatrics
Medical School
Available to mentor
Jeremy Adler, MD, MSc
Jeremy Adler, MD, Mac
Clinical Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Jeremy Adler, M.D., M.Sc. is a Clinical Professor in the Division of Pediatric Gastroenterology at the University of Michigan and serves as research faculty in the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center. Dr. Adler earned his M.D. degree at the University of South Florida College of Medicine. He completed his residency in pediatrics at Boston City Hospital and Boston Medical Center in 1997. He then practiced academic general pediatrics in New York for several years before moving to Michigan to train in pediatric gastroenterology at the University of Michigan. He then earned a Master of Science in Health and Health Care Research through in the Horace H. Rackham School of Graduate Studies at the University of Michigan, and had further training in the Advanced Improvement Methods program at Cincinnati Children’s Hospital. Dr. Adler joined the pediatric gastroenterology faculty at the University of Michigan in 2008.

    Dr. Adler's clinical and research interest is in the care of children and adolescents with Crohn's disease and ulcerative colitis (inflammatory bowel disease or IBD). His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.

    Dr. Adler is an NIH-funded researcher whose scientific research has been featured in the American Gastroenterology Association's headline news, on the cover of the journal Inflammatory Bowel Diseases, and in the Innovations in Health Care section of the Wall Street Journal. Dr. Adler is a leader in the field of pediatric IBD, and has served as consultant to the US Food and Drug Administration, and his work on prevention of disease complications and on developing methods for evaluating endoscopic findings has been used in national and international policies and guidelines on treating children and adults with IBD. Dr. Adler also serves as the Director of Research and Quality Improvement in Pediatric Gastroenterology, and as the Director of the Pediatric IBD Program at C.S. Mott Children’s Hospital at Michigan Medicine.

    Qualifications

    • Adaptive Leadership
      University of Michigan, United states
      2024
      Other
    • Linkage Leadership Academy
      University of Michigan, Ann Arbor, Michigan
      2015 - 2015
      Other
    • Advanced Improvement Methods (AIM), Center for Health Care Quality
      Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
      2012 - 2013
      Other
    • Master of Science in Health and Health Care Research, Robert Wood Johnson Master's Program
      University of Michigan Medical School, Ann Arbor, United States
      2008 - 2009
      Postdoctoral Research
    • Pediatric gastroenterology Fellowship
      C. S. Mott Children's Hospital, Ann Arbor, United States
      2005 - 2008
      Postdoctoral Research
    • Pediatric Residency
      Boston Medical Center, Boston, United States
      1994 - 1997
      Postdoctoral Research
    • MSc
      Horace H. Rackham School of Graduate Studies, University of Michigan, Ann Arbor, MI, United States
      2008 - 2009
    • MD
      University of South Florida College of Medicine, 4202 E Fowler Ave, Tampa, FL, 33620, United States
      1990 - 1994
    • BS
      University of Florida, Gainesville, FL, United States
      1986 - 1990

    Center Memberships

    • Center Member
      Institute for Healthcare Policy and Innovation

    Research Overview

    Dr. Adler focuses on improving care of children and adolescents with Crohn's disease and ulcerative colitis. His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.

    Recent Publications

    See All Publications
    • Journal Article
      High Rates of Seroprotection for Measles in Pediatric Patients with Inflammatory Bowel Disease.
      Caldera F, Hayney MS, Strople JA, Kastl AJ, Adler J, Boccieri M, Zhang X, Long MD, Kappelman MD. Am J Gastroenterol, 2026 May 20; DOI:10.14309/ajg.0000000000004050
      PMID: 42159717
    • Proceeding / Abstract / Poster
      824 SITE-SPECIFIC GENE-MICROBIAL INTERACTIONS IN CHILDREN WITH EARLY-ONSET CROHN’S DISEASE
      Kuffa P, Adler J, Ostrowski MP, Pickard JM, Lo BC, Inohara N, Núñez G, Caruso R. Gastrointestinal Endoscopy, 2026 May 6; 103 (5): s - 900. DOI:10.1016/s0016-5107(26)02312-6
    • Proceeding / Abstract / Poster
      824 SITE-SPECIFIC GENE-MICROBIAL INTERACTIONS IN CHILDREN WITH EARLY-ONSET CROHN’S DISEASE
      Kuffa P, Adler J, Ostrowski MP, Pickard JM, Lo BC, Inohara N, Núñez G, Caruso R. Gastroenterology, 2026 May 7; 170 (6): s - 900. DOI:10.1016/s0016-5085(26)02381-4
    • Journal Article
      Antibiotic Utilization for Perianal Fistulizing Complications Among Young Patients with Crohn’s Disease
      Gadepalli S, Tribble A, Rahman M, Manning L, Adler J. The Journal of Pediatrics, 2026 May 8; 115142 - 115142. DOI:10.1016/j.jpeds.2026.115142
    • Journal Article
      Mo1640 HIGH RATES OF SEROPROTECTION FOR MEASLES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
      Caldera F, Hayney MS, Strople JA, Kastl A, Adler J, Boccieri M, Zhang X, Long MD, Kappelman M. Gastroenterology, 2026 May 7; 170 (6): s - 1225. DOI:10.1016/s0016-5085(26)03079-9
    • Journal Article
      Mo1640 HIGH RATES OF SEROPROTECTION FOR MEASLES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
      Caldera F, Hayney MS, Strople JA, Kastl A, Adler J, Boccieri M, Zhang X, Long MD, Kappelman M. Gastrointestinal Endoscopy, 2026 May 6; 103 (5): s - 1225. DOI:10.1016/s0016-5107(26)03010-5
    • Journal Article
      Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study.
      Steiner SJ, Adler J, Saeed SA, Strauss RS, Howe KM, Sheahan A, Zhang R, Keihn KR, Harrow K, Olano KK, Evans DA, Lo KH, Zhang N, Kim L, Colletti RB, Volger S, ImproveCareNow Learning Health Network . J Pediatr Gastroenterol Nutr, 2026 Mar 2; DOI:10.1002/jpn3.70372
      PMID: 41766590
    • Additional Scholarship
      Aquamin® for Prevention of Ulcerative Colitis J-Pouch-Associated Intestinal Inflammation
      Adler J, Leis A, Aslam M. 2026 Mar 19;

    Featured News & Stories

    Smiling family photo of 5 members of the Kripke family. They appear to be dressed for a semi-formal event and are standing in an open space with green-cushioned seating visible behind them.
    Philanthropy News

    Family that overcame Crohn’s supports research for future patients

    Kripke family gift supports Chron's disease research at Michigan Medicine. This gift will advance pediatric medical research and patient care at U-M.
    Headshot of Blake Hardin, a man wearing a Michigan Medicine blue long sleeved shirt outdoors
    Points of Blue

    Blake Hardin, MD/MPH student: Merging research and advocacy with medicine

    University of Michigan medical student Blake Hardin shares his medical school experience in this Q&A, focusing on his interests in disability health and advocacy, surgical outcomes research, medical education and ways to foster belonging at UMMS
    Joanne standing in front of a research poster she created
    Points of Blue

    Joanne Constantin, Postdoc: Bridging the fields of public health and medicine

    In this interview, Joanne answers questions about her work as a postdoctoral fellow in Health & Healthcare Research and the real-world impact it’s having.
    shot in arm patient rolled up sleeve
    Health Lab

    Why anti-TNF drugs don’t work for some kids with Crohn's disease

    Research from Michigan Medicine investigated possible genetic factors for drug efficacy for children with Crohn’s disease. 
    syringes three in a row with one with a shot going into it on a light teal background
    Health Lab

    TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies

    Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data.